Document:

EX-10.15

 Exhibit 10.15 

VOR BIOPHARMA INC. 

Executive Severance and Change in Control Benefits Plan 

1. Establishment of Plan. Vor Biopharma Inc., a Delaware corporation, hereby establishes an unfunded severance benefits plan (the
“Plan”) that is intended to be a welfare benefit plan within the meaning of Section 3(1) of ERISA. The Plan is in effect for Covered Employees who experience a Covered Termination occurring after the Effective Date and before
the termination of this Plan. This Plan supersedes any and all (i) severance plans and separation policies applying to Covered Employees that may have been in effect before the Effective Date with respect to any termination that would, under
the terms of this Plan, constitute a Covered Termination and (ii) the provisions of any agreements between any Covered Employee and the Company that provide for severance benefits. 

2. Purpose. The purpose of the Plan is to establish the conditions under which Covered Employees will receive the severance benefits
described herein if employment with the Company (or its successor in a Change in Control) terminates under the circumstances specified herein. The severance benefits paid under the Plan are intended to assist Covered Employees in making a transition
to new employment and are not intended to be a reward for prior service with the Company. 
 3. Definitions. For purposes of this
Plan, 
 (a) “Accrued Obligations” shall mean (i) any earned but unpaid Base Salary as of the date the Covered
Employee’s employment is terminated, (ii) any accrued, but unused vacation time as of the date the Covered Employee’s employment is terminated, (iii) any vested benefits the Covered Employee may have under any employee benefit
plan of the Company as of the date the Covered Employee’s employment is terminated, (iv) any unpaid expense reimbursements accrued prior to the date the Covered Employee’s employment is terminated, and (iv) any unpaid but earned
bonus for a fiscal year preceding the year in which the Covered Employee’s employment is terminated that was earned and Board-approved but is unpaid as of the date the Covered Employee’s employment is terminated. 

(b) “Base Salary” shall mean, for any Covered Employee, such Covered Employee’s base rate of pay as in effect
immediately before a Covered Termination (or, if applicable, prior to the Change in Control, if greater) and exclusive of any bonuses, overtime pay, shift differentials, “adders,” any other form of premium pay, or other forms of
compensation. 
 (c) “Benefits Continuation” shall mean the continuation of benefits described in, subject to and in
accordance with Section 8 hereof. 
 (d) “Benefits Continuation Period” shall have the meaning set forth in
Section 8 hereof. 
 (e) “Board” shall mean the Board of Directors of the Company. 

(f) “Bonus” shall mean, for any Covered Employee, the target annual bonus for such Covered Employee, expressed as a
percentage of base salary, as may be adjusted from time to time by the Board or a committee thereof, without regard to whether the performance goals applicable to such bonus had been established or satisfied at the date of termination of employment.

 (g) “Cause” shall mean (i) the Covered Employee’s breach of any Restrictive Covenants Agreement with the
Company, (ii) the Covered Employee’s commission of, or the Covered Employee’s plea of “guilty” or “no contest” to, a felony or crime involving moral turpitude under the laws of the United States or any State,
(iii) the Covered Employee’s gross negligence or willful misconduct in the performance of his or her duties, (iv) the Covered Employee’s continuing willful failure to perform assigned duties after receiving written notification
of the failure from the Company, (v) the Covered Employee’s material failure to comply with the Company’s written policies, or (vi) the Covered Employee’s failure to cooperate in good faith with a governmental or internal

 
investigation of the Company or its directors, officers or employees, if the Company has requested such cooperation; provided, however, that “Cause” shall not be deemed to have occurred
pursuant to subsection (iii), (iv), (v) or (vi) hereof unless the Covered Employee has first received written notice from the Company specifying in reasonable detail the particulars of such grounds and that the Company intends to terminate the
Covered Employee’s employment for such grounds, and, if curable, the Covered Employee has failed to cure such grounds to the Company’s satisfaction within a period of thirty (30) days from the date of such notice. 

(h) “Change in Control” shall have the meaning provided in the Equity Incentive Plan. 

(i) “Change in Control Termination” shall mean a Termination Without Cause of a Covered Employee or a Resignation for
Good Reason by a Covered Employee, in either case, on or within the one (1) year period following the closing of a Change in Control. 

(j) “COBRA” shall mean the Consolidated Omnibus Budget Reconciliation Act. 

(k) “Code” shall mean the Internal Revenue Code of 1986, as amended. 

(l) “Committee” shall mean the Board of Directors of the Company or the Compensation Committee of such Board of
Directors. 
 (m) “Company” shall mean Vor Biopharma Inc., or, following a Change in Control, any successor thereto.

 (n) “Covered Employees” shall mean all Regular Full-Time Employees (both exempt and
non-exempt) who are Executives, who experience a Covered Termination and who are not designated as ineligible to receive severance benefits under the Plan as provided in Section 5 hereof. For the
avoidance of doubt, neither Temporary Employees nor Part-Time Employees are eligible for severance benefits under the Plan. An employee’s full-time, part-time or temporary status for the purpose of this Plan shall be determined in good faith by
the Plan Administrator upon review of the employee’s status immediately before termination. Any person who is classified by the Company as an independent contractor or third-party employee is not eligible for severance benefits even if such
classification is modified retroactively. 
 (o) “Covered Termination” shall mean a termination designated by the
Plan Administrator as (i) a Change in Control Termination or (ii) solely for Covered Employees who are Executives, a Non-Change in Control Termination. The Plan Administrator shall determine whether
a particular termination is a Change in Control Termination or a Non-Change in Control Termination, and may determine, based on the facts and circumstances, that a termination does not qualify as a Covered
Termination. For the avoidance of doubt, any employee of the Company who is not an Executive who experiences a Termination Without Cause or a Resignation for Good Reason in either case prior to or more than twelve (12) months after the closing
of a Change in Control, shall not have experienced a Covered Termination and shall not be entitled to receive any payments or benefits under this Plan. 

(p) “Disability” shall mean that the employee, due to a physical or mental disability, for a period of ninety
(90) consecutive days, or one hundred and eighty (180) days in the aggregate whether or not consecutive, during any three hundred and sixty-five (365) day period, is unable to perform the services required by the employee’s
position at the Company. A determination of Disability shall be made by a physician selected by the Company. 
 (q) “Delay
Period” shall have the meaning set forth in Section 13(b)(1) hereof. 
 (r) “Effective Date” shall mean
the date of the effectiveness of the Company’s registration statement with respect to its initial public offering. 
 (s)
“Equity Incentive Plan” shall mean the Company’s 2021 Equity Incentive Plan, as amended. 

  
 2 

 (t) “ERISA” shall mean the Employee Retirement Income Security Act
of 1974, as amended. 
 (u) “Exchange Act” shall mean the Securities and Exchange Act of 1934, as amended. 

(v) “Executive” shall mean any employee of the Company holding the title of Vice President or above. 

(w) “Non-Change in Control Termination” shall mean a Termination Without Cause
of a Covered Employee who is an Executive or a Resignation for Good Reason by a Covered Employee who is an Executive, in either case prior to or more than twelve (12) months after the closing of a Change in Control. 

(x) “Part-Time Employees” shall mean employees who are not Regular Full-Time Employees or Temporary Employees and are
treated as such by the Company. 
 (y) “Participants” shall mean Covered Employees. 

(z) “Plan Administrator” shall mean the Committee prior to a Change in Control and the Representative following a
Change in Control. 
 (aa) “Representative” shall mean one or more members of the Committee or other persons or
entities designated by the Committee prior to or in connection with a Change in Control that will have authority to administer and interpret the Plan upon and following. 

(bb) “Regular Full-Time Employees” shall mean employees, other than Temporary Employees, normally scheduled to work at
least thirty (30) hours a week unless the Company’s local practices, as from time to time in force, whether or not in writing, establish a different hours threshold for regular full-time employees. 

(cc) “Resignation for Good Reason” shall mean a Separation as a result of the Covered Employee’s resignation after
one of the following conditions without the Covered Employee’s written consent: (i) a material reduction in the employee’s Base Salary or target Bonus opportunity (unless such reduction is part of a broad-based salary reduction
applicable to the Company’s senior management); (ii) a material diminution in the employee’s authority, duties or responsibilities; (iii) a material breach by the Company of a material term of an agreement between such Covered
Employee and the Company concerning the terms and conditions of such Covered Employee’s employment with the Company; or (iv) a material change in the geographic location at which the employee must perform services to the Company (it being
understood that any change of forty (40) or more miles would be material). In order to establish a “Resignation for Good Reason,” an employee must provide written notice to the Company of the initial existence of the condition giving
rise to the Resignation for Good Reason, which notice must be provided within ninety (90) days of the initial existence of such condition, the Company must fail to cure the condition within thirty (30) days thereafter, and the
employee’s termination of employment must occur no later than thirty (30) days following the expiration of the Company’s cure period. 

(dd) “Restrictive Covenants Agreement” shall mean any invention, non-disclosure
agreement, non-competition or non-solicitation agreement or any similar agreement between the Covered Employee and the Company. 

(ee) “Section 409A” shall have the meaning set forth in Section 13 hereof. 

(ff) “Separation” shall mean a “separation from service,” as defined in the regulations under
Section 409A. 
 (gg) “Separation Agreement” shall have the meaning set forth in Section 6 hereof. 

(hh) “Separation Agreement Effective Date” shall have the meaning set forth in Section 13(c)(1) hereof. 

  
 3 

 (ii) “Temporary Employees” are employees treated as such by the
Company, whether or not in writing. 
 (jj) “Termination Without Cause” shall mean a Separation as a result of a
termination of the Covered Employee’s employment by the Company without Cause. 
 4. Coverage. Subject to satisfaction of the
eligibility and other requirements set forth in Sections 5 and 6 of this Plan, a Covered Employee will be entitled to receive severance benefits under this Plan if such employee experiences a Covered Termination while this Plan is in effect.

 5. Eligibility for Severance Benefits. The following employees will not be eligible for severance benefits, except to the
extent specifically determined in good faith otherwise by the Plan Administrator: (a) an employee who is terminated for Cause or by reason of death or Disability; (b) an employee who voluntarily retires or otherwise voluntarily terminates
his or her employment other than a Resignation for Good Reason at any time the case of an Executive or, on or within twelve months following a Change in Control in the case of a Covered Employee other than an Executive; and (c) an employee who
is employed for a specific period of time in accordance with the terms of a written offer letter or employment agreement. 
 6. Separation
Agreement; Timing of Severance Benefits. 
 (a) Receipt of any severance payments or benefits under the Plan requires that the
Covered Employee: (a) comply with the provisions of any applicable Restrictive Covenants Agreement with the Company, and other obligations to the Company; (b) have returned all Company property in the Covered Employee’s
possession on or prior to the Covered Employee’s last day of employment; (c) have resigned as a member of the Board or as a member of any board of directors of any subsidiary of the Company, to the extent the Covered Employee is then a
director of the Company or of any such subsidiary; (d) have entered into a separation agreement, in a form to be provided by and acceptable to the Company, that has become enforceable and irrevocable and that includes a general release of all
claims that the Covered Employee may have against the Company or persons affiliated with the Company, re-confirmation of the Covered Employee’s obligations under any applicable Restrictive Covenants
Agreement, and a 12-month post-employment non-competition provision (or an amount equal in length to the applicable Benefits Continuation Period, if longer than 12
months) (the “Separation Agreement”); and (e) comply with the provisions of the Separation Agreement. The Separation Agreement must become enforceable and irrevocable within the time period specified therein, but in any event
on or before the fifty-second (52nd) day following the date of the Covered Employee’s Separation. If the Covered Employee fails to execute without revocation the Separation Agreement within such period, the Covered Employee shall be entitled to
the Accrued Obligations only and no other severance payments or benefits. 
 (b) The Accrued Obligations (if any) shall be paid on or
before the time required by law or applicable policy, except to the extent any such payments would accelerate compensation in a manner inconsistent with Section 409A. The severance payments provided for in Section 7 hereof will be paid in
accordance with the terms of this Plan and the Company’s regularly scheduled payroll dates in effect from time to time and the Benefits Continuation will be paid at the time premium payments are made by other participants in the Company’s
health benefit plans generally. Subject to Section 13 hereof, the payments shall be made or commence on the first payroll date after the Separation Agreement Effective Date. 

7. Cash Severance. 
 (a)
Non-Change in Control Termination. In addition to any Accrued Obligations but subject to the requirements of Section 6 hereof, a Covered Employee who experiences a Non-Change in Control Termination shall be entitled to receive continuation of such employee’s monthly Base Salary for the Severance Period indicated in the table below opposite such employee’s title. 

  
 4 

			
	 Title of Participant
	  	Severance Period
	Chief Executive Officer	  	12 Months
	C-Level (other than CEO)	  	12 Months
	Vice President	  	6 Months

 (b) Change in Control Termination. In addition to any Accrued Obligations but subject to
the requirements of Section 6 hereof, a Covered Employee who experiences a Change in Control Termination shall be entitled to receive: 

(i) a single lump sum payment in an amount equal to the product of such employee’s annual Base Salary and the multiple indicated
in the table below opposite such employee’s title; and 
 (ii) a single lump sum payment in an amount equal to the product of
such employee’s Bonus and the multiple indicated in the table below opposite such employee’s title. 
  

			
	 Title of Participant
	  	Multiple
	Chief Executive Officer	  	Base: 1.5x
 Bonus: 1.5x

	C-Level (other than CEO)	  	Base: 1.0x
 Bonus: 1.0x

	Vice President	  	Base: 0.50x
 Bonus: 0.50x

 For purposes of this Section 7, a Covered Employee’s title shall be such employee’s title immediately prior to
the Covered Termination or, if such employee’s title was changed in connection with the Change in Control, immediately prior to such change in connection with the Change in Control. 

8. Benefits Continuation. Subject to Section 6, if a Covered Employee is eligible for and timely elect to continue health insurance
coverage under COBRA following a Covered Termination, the Company will pay the COBRA group health insurance premiums for the Covered Employee and his or her eligible dependents until the earliest of (A) the close of the applicable Benefits
Continuation Period, (B) the expiration of the Covered Employee’s eligibility for the continuation coverage under COBRA, or (C) the date when the Covered Employee become eligible for substantially equivalent health insurance coverage
in connection with new employment or self-employment. For purposes of this Section, references to COBRA premiums shall not include any amounts payable by the Covered Employee under a Section 125 health care reimbursement plan under the Code.
Notwithstanding the foregoing, if at any time the Company determines, in its sole discretion, that it cannot pay the COBRA premiums without potentially incurring financial costs or penalties under applicable law (including, without limitation,
Section 2716 of the Public Health Service Act), then regardless of whether the Covered Employee elects continued health coverage under COBRA, and in lieu of providing the COBRA premiums, the Company will instead pay the Covered Employee on the
last day of each remaining month of the applicable Benefits Continuation Period, a fully taxable cash payment equal to the COBRA premiums for that month, subject to applicable tax withholdings (such amount, the “Health Care Benefit
Payment”). The Health Care Benefit Payment shall be paid in monthly installments on the same schedule that the COBRA premiums would otherwise have been paid and shall be equal to the amount that the Company would have otherwise paid for
COBRA premiums, and shall be paid until the earlier of (i) expiration of the applicable Benefits Continuation Period or (ii) the date the Covered Employee voluntarily enroll in a health insurance plan offered by another employer or entity.

  
 5 

					
	 Title of Participant
	  	Benefits Continuation Period –
Non-Change in Control
Termination	  	Benefits Continuation Period –
Change in Control Termination
	Chief Executive Officer	  	12 months	  	18 months
	C-Level (other than CEO)	  	12 months	  	12 months
	Vice President	  	6 months	  	6 months

 9. Equity Awards. In the event of a Change in Control Termination, subject to Section 6 hereof and
except to the extent provided otherwise in the applicable award agreement, all of the Covered Employee’s equity awards that were granted on or after the Company’s initial public offering and are outstanding and unvested as of such
termination and that vest based on the Covered Employee’s continued service with the Company, will vest and become fully exercisable or non-forfeitable on the date of such termination. Any equity awards
that were granted on or after the Company’s initial public offering and are subject to vesting based on the attainment of performance goals shall vest and become exercisable according to their individual award agreements. For the avoidance of
doubt, a Covered Employee’s equity awards may also be subject to potential vesting acceleration that may occur in connection with a Change in Control as set forth in the equity incentive plan under which the equity award was granted, and, for
clarity, to the extent a Covered Employee’s unvested equity award is assumed, continued or substituted for in a Change in Control pursuant to such applicable equity incentive plan, the vesting acceleration described in this Section shall apply
to such assumed, continued or substituted award, as applicable. Except to the extent set forth herein, in the event of a Covered Termination all of the Covered Employee’s equity awards will continue to be dictated by the terms of the applicable
award agreements. 
 10. Recoupment. If a Covered Employee fails to comply with the terms of this Plan, including the
provisions of Section 6 above, and/or fails to comply with the terms of the Separation Agreement, the Company may require repayment to the Company of any benefits described in Sections 7 and 8 above that the Covered Employee has already
received to the extent permitted by applicable law and with the “value” determined in the sole and good faith discretion of the Plan Administrator. Payment is due in cash or by check within thirty (30) days, or such earlier date as
may be required by law or by any clawback policy that the Company adopts, after the Company provides notice to a Covered Employee that it is enforcing this provision. Any benefits described in Sections 7 and 8 above not yet received by such Covered
Employee will be immediately forfeited. 
 11. Death; Disability. If a Participant dies or becomes Disabled after the date of his or
her Covered Termination but before all payments or benefits to which such Participant is entitled pursuant to this Plan have been paid or provided, payments will be made to any beneficiary or legal representative designated by the Participant prior
to or in connection with such Participant’s Covered Termination or, if no such beneficiary or legal representative has been designated, to the Participant’s estate. For the avoidance of doubt, if a Participant dies or is permanently
Disabled during the Benefits Continuation period provided for the Participant in Section 8, Benefits Continuation will continue for the Participant’s applicable dependents for the remainder of the applicable Benefits Continuation
Period provided for such Participant in Section 8. 
 12. Withholding. The Company may withhold from any payment or benefit under
the Plan: (a) any federal, state, or local income or payroll taxes required by law to be withheld with respect to such payment; (b) such sum as the Company may reasonably estimate is necessary to cover any taxes for which the Company may
be liable and which may be assessed with regard to such payment; and (c) such other amounts as appropriately may be withheld under the Company’s payroll policies and procedures from time to time in effect. 

13. Section 409A. It is expected that the payments and benefits provided under this Plan will be exempt from or
compliant with Section 409A of the Code, and the guidance issued thereunder (“Section 409A”). The Plan shall be interpreted consistent with this intent to the maximum extent permitted and generally, with the
provisions of Section 409A. A termination of employment shall not be deemed to have occurred for purposes of any provision of this Plan providing for the payment of any amounts or benefits upon or following a termination of employment (which
amounts or benefits constitute nonqualified deferred compensation within the meaning of Section 409A) unless such termination is also Separation and, for purposes of any such provision of this Plan, references to a “termination,”
“termination of employment” or like terms shall mean Separation. Neither the Participant nor the Company shall have the right to accelerate or defer the delivery of any payment or benefit except to the extent specifically permitted or
required by Section 409A. 

  
 6 

 To the extent the severance payments or benefits under this Plan are subject to Section 409A, the
following rules shall apply with respect to distribution of the payments and benefits, if any, to be provided to Participants under this Plan: 

(a) Each installment of the payments and benefits provided under this Plan will be treated as a separate “payment” for
purposes of Section 409A. Whenever a payment under this Plan specifies a payment period with reference to a number of days (e.g., “payment shall be made within ten (10) days following the date of termination”), the actual
date of payment within the specified period shall be in the Company’s sole discretion. Notwithstanding any other provision of this Plan to the contrary, in no event shall any payment under this Plan that constitutes “non-qualified deferred compensation” for purposes of Section 409A be subject to transfer, offset, counterclaim or recoupment by any other amount unless otherwise permitted by Section 409A. 

(b) Notwithstanding any other payment provision herein to the contrary, if the Company or appropriately-related affiliates become
publicly-traded and a Covered Employee is deemed on the date of termination to be a “specified employee” within the meaning of that term under Code Section 409A(a)(2)(B) with respect to such entity, then each of the following shall
apply: 
 (i) With regard to any payment that is considered “non-qualified deferred
compensation” under Section 409A payable on account of a Separation, such payment shall be made on the date which is the earlier of (A) the day following the expiration of the six (6) month period measured from the date of such
Separation of the Covered Employee, and (B) the date of the Covered Employee’s death (the “Delay Period”) to the extent required under Section 409A. Upon the expiration of the Delay Period, all payments delayed
pursuant to this provision (whether otherwise payable in a single sum or in installments in the absence of such delay) shall be paid to or for the Covered Employee in a lump sum, and all remaining payments due under this Plan shall be paid or
provided for in accordance with the normal payment dates specified herein; and 
 (ii) To the extent that any benefits to be provided
during the Delay Period are considered “non-qualified deferred compensation” under Section 409A payable on account of a Separation, and such benefits are not otherwise exempt from
Section 409A, the Covered Employee shall pay the cost of such benefits during the Delay Period, and the Company shall reimburse the Covered Employee, to the extent that such costs would otherwise have been paid by the Company or to the extent
that such benefits would otherwise have been provided by the Company at no cost to the Covered Employee, the Company’s share of the cost of such benefits upon expiration of the Delay Period. Any remaining benefits shall be reimbursed or
provided by the Company in accordance with the procedures specified in this Plan. 
 (c) To the extent that severance benefits
pursuant to this Plan are conditioned upon the execution and nonrevocation of a Separation Agreement, the Covered Employee shall forfeit all rights to such payments and benefits unless such separation agreement is signed and delivered (and no longer
subject to revocation, if applicable) within fifty-two (52) days following the date of the termination of the Covered Employee’s employment with the Company. If the Separation Agreement is no longer
subject to revocation as provided in the preceding sentence, then the following shall apply: 
 (i) To the extent any severance
benefits to be provided are not “non-qualified deferred compensation” for purposes of Section 409A, then such benefits shall commence upon the first scheduled payment date immediately after the
date the Separation Agreement is executed and no longer subject to revocation (the “Separation Agreement Effective Date”). The first such cash payment shall include all amounts that otherwise would have been due prior thereto under
the terms of this Agreement applied as though such payments commenced immediately upon the termination of Covered Employee’s employment with the Company, and any payments made after the Separation Agreement Effective Date shall continue as
provided herein. The delayed benefits shall in any event expire at the time such benefits would have expired had such benefits commenced immediately following the termination of Covered Employee’s employment with the Company. 

(ii) To the extent any such severance benefits to be provided are “non-qualified deferred
compensation” for purposes of Section 409A, then the Separation Agreement must become irrevocable within fifty-two (52) days of the date of termination and benefits shall be made or commence
upon the date provided in Section 6, provided that if the 52nd day following the termination of Executive’s employment with the Company falls in the calendar year following the calendar year containing the date of termination, the benefits
will be made no earlier 

  
 7 

 
than the first business day of that following calendar year. The first such cash payment shall include all amounts that otherwise would have been due prior thereto under the terms of this
Agreement had such payments commenced immediately upon the termination of Executive’s employment with the Company, and any payments made after the first such payment shall continue as provided herein. The delayed benefits shall in any event
expire at the time such benefits would have expired had such benefits commenced immediately following the termination of Executive’s employment with the Company. 

(d) The Company makes no representations or warranties and shall have no liability to any Participant or any other person, other than
with respect to payments made by the Company in violation of the provisions of this Plan, if any provisions of or payments under this Plan are determined to constitute deferred compensation subject to Section 409A but not to satisfy the
conditions of that section. 
 14. Section 280G 

(a) If any payment or benefit a Covered Employee will or may receive from the Company or otherwise (a “Payment”) would
(i) constitute a “parachute payment” within the meaning of Section 280G of the Code, and (ii) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”),
then any such Payment shall be equal to the Reduced Amount. The “Reduced Amount” shall be either (x) the largest portion of the Payment that would result in no portion of the Payment (after reduction) being subject to the
Excise Tax or (y) the largest portion, up to and including the total, of the Payment, whichever amount (i.e., the amount determined by clause (x) or by clause (y)), after taking into account all applicable federal, state and local
employment taxes, income taxes, and the Excise Tax (all computed at the highest applicable marginal rate), results in the Covered Employee’s receipt, on an after-tax basis, of the greater economic benefit
notwithstanding that all or some portion of the Payment may be subject to the Excise Tax. If a reduction in a Payment is required pursuant to the preceding sentence and the Reduced Amount is determined pursuant to clause (x) of the preceding
sentence, the reduction shall occur in the manner (the “Reduction Method”) that results in the greatest economic benefit for the Covered Employee. If more than one method of reduction will result in the same economic benefit, the
items so reduced will be reduced pro rata (the “Pro Rata Reduction Method”). 
 (b) Notwithstanding any provisions in
this Section above to the contrary, if the Reduction Method or the Pro Rata Reduction Method would result in any portion of the Payment being subject to taxes pursuant to Section 409A that would not otherwise be subject to taxes pursuant to
Section 409A, then the Reduction Method and/or the Pro Rata Reduction Method, as the case may be, shall be modified so as to avoid the imposition of taxes pursuant to Section 409A as follows: (A) as a first priority, the modification
shall preserve to the greatest extent possible, the greatest economic benefit for the Covered Employee as determined on an after-tax basis; (B) as a second priority, Payments that are contingent on future
events (e.g., being terminated without Cause), shall be reduced (or eliminated) before Payments that are not contingent on future events; and (C) as a third priority, Payments that are “deferred compensation” within the meaning
of Section 409A shall be reduced (or eliminated) before Payments that are not deferred compensation within the meaning of Section 409A. 

(c) The Company shall appoint a nationally recognized accounting or law firm to make the determinations required by this Section. The
Company shall bear all expenses with respect to the determinations by such accounting or law firm required to be made hereunder. If the Covered Employee receives a Payment for which the Reduced Amount was determined pursuant to clause (x) above
and the Internal Revenue Service determines thereafter that some portion of the Payment is subject to the Excise Tax, Covered Employee agrees to promptly return to the Company a sufficient amount of the Payment (after reduction pursuant to clause
(x) above) so that no portion of the remaining Payment is subject to the Excise Tax. For the avoidance of doubt, if the Reduced Amount was determined pursuant to clause (y) above, the Covered Employee shall have no obligation to return any
portion of the Payment pursuant to the preceding sentence. 
 15. Clawback; Recovery. All payments and severance benefits provided
under the Plan will be subject to recoupment in accordance with any clawback policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company’s securities are
listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law. In addition, the Plan Administrator may impose such other clawback, recovery or recoupment provisions as the Plan
Administrator determines necessary or appropriate, including but not limited to a reacquisition right in respect 

  
 8 

 
of previously acquired shares of common stock of the Company or other cash or property upon the occurrence of a termination of employment for Cause. No recovery of compensation under such a
clawback policy will be an event giving rise to an event permitting a Resignation for Good Reason, constructive termination, or any similar term under any plan of or agreement with the Company. 

16. Indemnification. To the extent permitted by law, all employees, officers, directors, agents and representatives of the Company, to
the extent not otherwise indemnified by the Company by agreement, pursuant to the Company’s Certificate of Incorporation (as may be amended and/or restated from time to time) or otherwise, shall be indemnified by the Company and held harmless
against any claims and the expenses of defending against such claims, resulting from any action or conduct relating to the administration of the Plan, whether as a member of the Board or the Committee or otherwise, except to the extent that such
claims arise from gross negligence, willful neglect, or willful misconduct. 
 17. Plan Not an Employment Contract. The Plan is not a
contract between the Company and any employee, nor is it a condition of employment of any employee. Nothing contained in the Plan gives, or is intended to give, any employee the right to be retained in the service of the Company, or to interfere
with the right of the Company to discharge or terminate the employment of any employee at any time and for any reason. No employee shall have the right or claim to benefits beyond those expressly provided in this Plan, if any. All rights and claims
are limited as set forth in the Plan. 
 18. Severability. In case any one (1) or more of the provisions of this Plan (or part
thereof) shall be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect the other provisions hereof, and this Plan shall be construed as if such invalid, illegal or
unenforceable provisions (or part thereof) never had been contained herein. 
 19. Non-Assignability. No right or interest of any
Covered Employee in the Plan shall be assignable or transferable in whole or in part either directly or by operation of law or otherwise, including, but not limited to, execution, levy, garnishment, attachment, pledge or bankruptcy. 

20. Integration With Other Pay or Benefits Requirements. The severance payments and benefits provided for in the Plan are the maximum
benefits that the Company will pay to Covered Employees on a Covered Termination, except to the extent otherwise specifically provided in a separate agreement entered into on or after the Effective Date. To the extent that the Company owes any
amounts in the nature of severance benefits under any other program, policy or plan of the Company that is not otherwise superseded by this Plan, or to the extent that any federal, state or local law, including, without limitation, so-called “plant closing” laws, requires the Company to give advance notice or make a payment of any kind to an employee because of that employee’s involuntary termination due to a layoff, reduction
in force, plant or facility closing, sale of business, or similar event, the benefits provided under this Plan or the other arrangement shall either be reduced or eliminated to avoid any duplication of payment. The Company intends for the benefits
provided under this Plan to partially or fully satisfy any and all statutory obligations that may arise out of an employee’s involuntary termination for the foregoing reasons and the Company shall so construe and implement the terms of the
Plan. 
 21. Amendment or Termination. The Board or the Committee may amend, modify, or terminate the Plan at any time in its sole
discretion; provided, however, that (a) any such amendment, modification or termination made prior to a Change in Control that adversely affects the rights of any Covered Employee shall be unanimously approved by the Company’s Board of
Directors, including any independent director(s), (b) no such amendment, modification or termination may affect the rights of a Covered Employee then receiving payments or benefits under the Plan without the consent of such person, and (c) no
such amendment, modification or termination made after a Change in Control shall be effective for one (1) year. 
 22. Interpretation
and Administration. Prior to the closing of a Change in Control, the Committee shall be the Plan Administrator and shall have the exclusive discretion and authority to establish rules, forms, and procedures for the administration of the Plan and
to construe and interpret the Plan and to decide any and all questions of fact, interpretation, definition, computation or administration arising in connection with the operation of the Plan, including, but not limited to, the eligibility to
participate in the Plan and amount of benefits paid under the Plan. The rules, interpretations, computations and other actions of the Committee shall be binding and conclusive on all persons. 

  
 9 

 
Upon and after the closing of a Change in Control, the Plan will be interpreted and administered in good faith by the Representative who shall be the Plan Administrator during such period. All
actions taken by the Representative in interpreting the terms of the Plan and administering the Plan upon and after the closing of a Change in Control will be final and binding on all Covered Employees. Any references in this Plan to the
“Committee” or “Plan Administrator” with respect to periods following the closing of a Change in Control shall mean the Representative 

23. Legal Construction. This Plan is intended to be governed by and shall be construed in accordance with ERISA and, to the extent not
preempted by ERISA, the laws of the Commonwealth of Massachusetts. 
 24. Claims, Inquiries and Appeals. 

(a) Applications for Benefits and Inquiries. Any application for benefits, inquiries about the Plan or inquiries about present or future
rights under the Plan must be submitted to the Plan Administrator in writing by an applicant (or his or her authorized representative). The Plan Administrator is: 

Vor Biopharma Inc. 
 Compensation
Committee of the Board of Directors or Representative 
 Attention to: Corporate Secretary 

100 Cambridgepark Drive, Suite 400 

Cambridge, Massachusetts 02140 

(b) Denial of Claims. In the event that any application for benefits is denied in whole or in part, the Plan Administrator must provide
the applicant with written or electronic notice of the denial of the application, and of the applicant’s right to review the denial. Any electronic notice will comply with the regulations of the U.S. Department of Labor. The notice of denial
will be set forth in a manner designed to be understood by the applicant and will include the following: 
 (i) the specific reason
or reasons for the denial; 
 (ii) references to the specific Plan provisions upon which the denial is based; 

(iii) a description of any additional information or material that the Plan Administrator needs to complete the review and an
explanation of why such information or material is necessary; and 
 (iv) an explanation of the Plan’s review procedures and the
time limits applicable to such procedures, including a statement of the applicant’s right to bring a civil action under Section 502(a) of ERISA following a denial on review of the claim, as described in (d) below. 

This notice of denial will be given to the applicant within 90 days after the Plan Administrator receives the application, unless special
circumstances require an extension of time, in which case, the Plan Administrator has up to an additional 90 days for processing the application. If an extension of time for processing is required, written notice of the extension will be furnished
to the applicant before the end of the initial 90 day period. 
 This notice of extension will describe the special circumstances
necessitating the additional time and the date by which the Plan Administrator is to render its decision on the application. 
 (c)
Request for a Review. Any person (or that person’s authorized representative) for whom an application for benefits is denied, in whole or in part, may appeal the denial by submitting a request for a review to the Plan Administrator within
60 days after the application is denied. A request for a review shall be in writing and shall be addressed to: 
 Vor Biopharma Inc. 

Compensation Committee of the Board of Directors or Representative 

Attention to: Corporate Secretary 

100 Cambridgepark Drive, Suite 400 

Cambridge, Massachusetts 02140 

  
 10 

 A request for review must set forth all of the grounds on which it is based, all facts in support of the
request and any other matters that the applicant feels are pertinent. The applicant (or his or her representative) shall have the opportunity to submit (or the Plan Administrator may require the applicant to submit) written comments, documents,
records, and other information relating to his or her claim. The applicant (or his or her representative) shall be provided, upon request and free of charge, reasonable access to, and copies of, all documents, records and other information relevant
to his or her claim. The review shall take into account all comments, documents, records and other information submitted by the applicant (or his or her representative) relating to the claim, without regard to whether such information was submitted
or considered in the initial benefit determination. 
 (d) Decision on Review. The Plan Administrator will act on each request for
review within 60 days after receipt of the request, unless special circumstances require an extension of time (not to exceed an additional 60 days), for processing the request for a review. If an extension for review is required, written notice of
the extension will be furnished to the applicant within the initial 60 day period. This notice of extension will describe the special circumstances necessitating the additional time and the date by which the Plan Administrator is to render its
decision on the review. The Plan Administrator will give prompt, written or electronic notice of its decision to the applicant. Any electronic notice will comply with the regulations of the U.S. Department of Labor. In the event that the Plan
Administrator confirms the denial of the application for benefits in whole or in part, the notice will set forth, in a manner calculated to be understood by the applicant, the following: 

(i) the specific reason or reasons for the denial; 

(ii) references to the specific Plan provisions upon which the denial is based; 

(iii) a statement that the applicant is entitled to receive, upon request and free of charge, reasonable access to, and copies of, all
documents, records and other information relevant to his or her claim; and 
 (iv) a statement of the applicant’s right to bring
a civil action under Section 502(a) of ERISA. 
 (e) Rules and Procedures. The Plan Administrator will establish rules and
procedures, consistent with the Plan and with ERISA, as necessary and appropriate in carrying out its responsibilities in reviewing benefit claims. The Plan Administrator may require an applicant who wishes to submit additional information in
connection with an appeal from the denial of benefits to do so at the applicant’s own expense. 
 (f) Exhaustion of Remedies. No
legal action for benefits under the Plan may be brought until the applicant (i) has submitted a written application for benefits in accordance with the procedures described by (a) above, (ii) has been notified by the Plan
Administrator that the application is denied, (iii) has filed a written request for a review of the application in accordance with the appeal procedure described in (c) above, and (iv) has been notified that the Plan Administrator has
denied the appeal. Notwithstanding the foregoing, if the Plan Administrator does not respond to an Eligible Employee’s claim or appeal within the relevant time limits specified in this Section 25, the Eligible Employee may bring legal
action for benefits under the Plan pursuant to Section 502(a) of ERISA. 
 25. Basis of Payments to and from Plan. The
Plan shall be unfunded, and all cash payments under the Plan shall be paid only from the general assets of the Company. 
 26. Other Plan
Information. 
 (a) Employer and Plan Identification Numbers. The Employer Identification Number assigned to the Company (which is
the “Plan Sponsor” as that term is used in ERISA) by the Internal Revenue Service is 77-0424412. The Plan Number assigned to the Plan by the Plan Sponsor pursuant to the instructions of the Internal
Revenue Service is 510. 

  
 11 

 (b) Ending Date for Plan’s Fiscal Year. The date of the end of the fiscal year
for the purpose of maintaining the Plan’s records is December 31. 
 (c) Agent for the Service of Legal Process. The agent for
the service of legal process with respect to the Plan is: 
 Vor Biopharma Inc. 

Compensation Committee of the Board of Directors or Representative 

Attention to: Corporate Secretary 

100 Cambridgepark Drive, Suite 400 

Cambridge, Massachusetts 02140 
 In addition,
service of legal process may be made upon the Plan Administrator. 
 (d) Plan Sponsor. The “Plan Sponsor” is: 

Vor Biopharma Inc. 
 Compensation
Committee of the Board of Directors or Representative 
 100 Cambridgepark Drive, Suite 400 

Cambridge, Massachusetts 02140 

(617) 655-6580 

(e) Plan Administrator. The Plan Administrator is the Committee prior to the closing of a Change in Control and the Representative upon
and following the closing of a Change in Control. The Plan Administrator’s contact information is: 
 Vor Biopharma Inc. 

Compensation Committee of the Board of Directors or Representative 

100 Cambridgepark Drive, Suite 400 

Cambridge, Massachusetts 02140 

(617) 655-6580 

The Plan Administrator is the named fiduciary charged with the responsibility for administering the Plan. 

27. Statement of ERISA Rights. Participants in this Plan (which is a welfare benefit plan sponsored by Vor Biopharma Inc.) are
entitled to certain rights and protections under ERISA. If you are an Eligible Employee, you are considered a participant in the Plan and, under ERISA, you are entitled to: 

(a) Receive Information About Your Plan and Benefits 

(i) Examine, without charge, at the Plan Administrator’s office and at other specified locations, such as worksites, all documents
governing the Plan and a copy of the latest annual report (Form 5500 Series), if applicable, filed by the Plan with the U.S. Department of Labor and available at the Public Disclosure Room of the Employee Benefits Security Administration; 

(ii) Obtain, upon written request to the Plan Administrator, copies of documents governing the operation of the Plan and copies of the
latest annual report (Form 5500 Series), if applicable, and an updated (as necessary) Summary Plan Description. The Administrator may make a reasonable charge for the copies; and 

(iii) Receive a summary of the Plan’s annual financial report, if applicable. The Plan Administrator is required by law to furnish
each Eligible Employee with a copy of this summary annual report. 

  
 12 

 (b) Prudent Actions by Plan Fiduciaries. In addition to creating rights for Plan
Eligible Employees, ERISA imposes duties upon the people who are responsible for the operation of the employee benefit plan. The people who operate the Plan, called “fiduciaries” of the Plan, have a duty to do so prudently and in the
interest of you and other Eligible Employees and beneficiaries. No one, including your employer, your union or any other person, may fire you or otherwise discriminate against you in any way to prevent you from obtaining a Plan benefit or exercising
your rights under ERISA. 
 (c) Enforce Your Rights. If your claim for a Plan benefit is denied or ignored, in whole or in part, you
have a right to know why this was done, to obtain copies of documents relating to the decision without charge, and to appeal any denial, all within certain time schedules. 

Under ERISA, there are steps you can take to enforce the above rights. For instance, if you request a copy of Plan documents or the latest
annual report from the Plan, if applicable, and do not receive them within 30 days, you may file suit in a Federal court. In such a case, the court may require the Plan Administrator to provide the materials and pay you up to $110 a day until you
receive the materials, unless the materials were not sent because of reasons beyond the control of the Plan Administrator. 
 If you have a
claim for benefits which is denied or ignored, in whole or in part, you may file suit in a state or Federal court. 
 If you are
discriminated against for asserting your rights, you may seek assistance from the U.S. Department of Labor, or you may file suit in a Federal court. The court will decide who should pay court costs and legal fees. If you are successful, the court
may order the person you have sued to pay these costs and fees. If you lose, the court may order you to pay these costs and fees, for example, if it finds your claim is frivolous. 

(d) Assistance with Your Questions. If you have any questions about the Plan, you should contact the Plan Administrator. If you have any
questions about this statement or about your rights under ERISA, or if you need assistance in obtaining documents from the Plan Administrator, you should contact the nearest office of the Employee Benefits Security Administration, U.S. Department of
Labor, listed in your telephone directory or the Division of Technical Assistance and Inquiries, Employee Benefits Security Administration, U.S. Department of Labor, 200 Constitution Avenue N.W., Washington, D.C. 20210. You may also obtain certain
publications about your rights and responsibilities under ERISA by calling the publications hotline of the Employee Benefits Security Administration. 

Adopted by the Board: January 19, 2021 

  
 13Exhibit 10.1

 

Execution Version

 

 

 

DATED JANUARY 31, 2021

 

AMONG

 

KISMET ACQUISITION ONE CORP

(The Company)

 

and

 

KISMET SPONSOR LIMITED

(The Purchaser)

 

and

 

Nexters
Inc.

 

(Pubco)

 

 

 

AMENDED AND RESTATED FORWARD PURCHASE
AGREEMENT

 

 

 

     

     

    

 

This Amended and Restated Forward Purchase
Agreement (this “Agreement”) is entered into as of January 31, 2021, by and among (i) Kismet Acquisition One
Corp., a British Virgin Islands business company with limited liability (the “Company”), (ii) Kismet Sponsor
Limited, a business company incorporated in the British Virgin Islands with limited liability (the “Purchaser”).
(iii) Nexters Inc., a British Virgin Islands business company (“Pubco”). The Company, the Purchaser and
Pubco are sometimes referred to herein individually as a “party” and, collectively, as the “parties.”
Any capitalized term used but not defined in this Agreement will have the meaning ascribed to such term in that certain business
combination agreement, dated on or around the date hereof, by and among (i) the Company, (ii) Sponsor (solely in its capacity
as a representative of the shareholders of Kismet), (iii) Pubco, (iv) Nexters Global Ltd., a private limited liability company
domiciled in Cyprus (the “Target Company”), (v) the shareholders of the Target Company set forth on the signature
pages thereto and (vi) Fantina Holdings Limited, a private limited liability company domiciled in Cyprus, solely in its capacity
as the representative of such shareholders (the “Business Combination Agreement”).

 

		(A)	WHEREAS, the Company was organized for the purpose of acquiring, engaging in a share exchange,
share reconstruction and amalgamation, contractual control arrangement with, purchasing all or substantially all of the assets
of, or engaging in any other similar initial business combination with one or more businesses or entities (a “Business
Combination”);

 

		(B)	WHEREAS, in connection with the Company’s initial public offering (the “IPO”),
the Company and the Purchaser entered into the forward purchase agreement dated August 5, 2020 (the “Original Agreement”),
pursuant to which concurrently with the closing of a Business Combination, the Company would issue and sell, and the Purchaser
would purchase, on a private placement basis, 2,000,000 units of the Company (the “Company Forward Purchase Units”)
consisting of 2,000,000 ordinary shares of the Company, no par value per share (the “Company Ordinary Shares”
generally, and the 2,000,000 Company Ordinary Shares subject to the purchase under the Original Agreement, the “Company
Forward Purchase Shares”) and 1,000,000 warrants of the Company, with each warrant entitling the Purchaser to purchase
one Company Ordinary Share on the same terms as each warrant of the Company sold as part of the units of the Company in the IPO
(the “Company Forward Purchase Warrants” and, collectively with the Company Forward Purchase Units and the Company
Forward Purchase Shares, the “Company Forward Purchase Securities”) on the terms and conditions set forth therein;

 

		(C)	WHEREAS, the Company has proposed to effect a Business Combination on the terms, and subject to
the conditions, set forth in the Business Combination Agreement (the “Transaction”);

 

		(D)	WHEREAS, the Original Agreement is terminated at, and conditional upon, the Merger Closing occurring;
and

 

    2

     

    

 

		(E)	WHEREAS, in connection with the Transaction, the Company and the Purchaser wish to amend and restate
the Original Agreement in its entirety as provided herein to, among other matters set forth herein, (i) an increase in the FPS
Purchase Price (as defined in the Original Agreement) from $20,000,000 to $50,000,000 and (ii) a replacement of the commitment
by the Purchaser to acquire the Company Forward Purchase Securities with a commitment by the Purchaser to acquire 5,000,000 Pubco
Ordinary Shares (the “Pubco Forward Purchase Shares”) and 1,000,000 Pubco Public Warrants (the “Pubco
Forward Purchase Warrants” and collectively with the Pubco Forward Purchase Shares, the “Pubco Forward Purchase
Securities”).

 

NOW, THEREFORE, in consideration of the
premises, representations, warranties and the mutual covenants contained in this Agreement, and for other good and valuable consideration,
the receipt, sufficiency and adequacy of which are hereby acknowledged, the parties hereto agree as follows:

 

		1.	Sale and Purchase.

 

		(a)	Forward Purchase Securities.

 

		(i)	Pursuant to the terms and subject to the conditions of this Agreement, Pubco shall issue and sell
to the Purchaser, and the Purchaser shall purchase from Pubco, the Pubco Forward Purchase Securities for an aggregate purchase
price of $50,000,000 (the “FPS Purchase Price”).

 

		(ii)	Each Pubco Forward Purchase Warrant will have the same terms as each warrant of the Company sold
as part of the units of the Company in the IPO, and will be subject to the terms and conditions of the Warrant Agreement to be
entered into between Pubco and Continental Stock Transfer & Trust Company, as warrant agent, in connection with the Transaction
(the “Warrant Agreement”). Each Pubco Forward Purchase Warrant will entitle the holder thereof to purchase one
(1) Pubco Ordinary Share at a price of $11.50 per share, subject to adjustment as described in the Warrant Agreement, and only
whole Pubco Forward Purchase Warrants will be exercisable. The Pubco Forward Purchase Warrants will become exercisable thirty (30)
days after the Merger Closing, and will expire five (5) years after the Share Acquisition Closing or earlier upon redemption or
the liquidation of Pubco, as described in the Warrant Agreement.

 

		(iii)	Pubco shall require the Purchaser to purchase the Pubco Forward Purchase Securities by delivering
notice to the Purchaser, at least ten (10) Business Days before the Merger Closing, specifying the anticipated date of the Merger
Closing, and instructions for wiring the FPS Purchase Price to Pubco. At least two (2) Business Days before the anticipated date
of the Merger Closing specified in such notice, the Purchaser shall deliver the FPS Purchase Price to Pubco in cash via wire transfer
to the account specified in such notice. If the Share Acquisition Closing does not occur within thirty (30) days after the FPS
Closing, Pubco shall automatically return to the Purchaser the FPS Purchase Price, provided that the return of the FPS Purchase
Price by Pubco shall not terminate the Agreement or otherwise relieve any party of any of its obligations hereunder. For the purposes
of this Agreement, “Business Day” means any day, other than a Saturday or a Sunday, that is neither a legal
holiday nor a day on which banking institutions are generally authorized or required by law or regulation to close in the City
of New York, New York.

 

    3

     

    

 

		(iv)	The closing of the sale of the Pubco Forward Purchase Securities (the “FPS Closing”)
shall be held after, and conditional upon, the Merger Closing and prior to the Share Acquisition Closing. At the FPS Closing, Pubco
will issue to the Purchaser the Pubco Forward Purchase Securities, each registered in the name of the Purchaser.

 

		(b)	Delivery of Forward Purchase Securities.

 

		(i)	Pubco shall register the Purchaser as the owner of the Pubco Forward Purchase Securities purchased
by the Purchaser hereunder in the register of members of Pubco and with Pubco’s transfer agent by book entry on or promptly
after (but in no event more than two (2) Business Days after) the date of the FPS Closing.

 

		(ii)	Each register and book entry for the Pubco Forward Purchase Securities shall contain a notation,
and each certificate (if any) evidencing the Pubco Forward Purchase Securities shall be stamped or otherwise imprinted with a legend,
in substantially the following form:

 

“THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS
OF ANY STATE OR OTHER JURISDICTION, AND MAY NOT BE TRANSFERRED IN VIOLATION OF SUCH ACT AND LAWS.”

 

		(c)	Legend Removal. If the Pubco Forward Purchase Securities are eligible to be sold without
restriction under, and without Pubco being in compliance with the current public information requirements of, Rule 144 under the
Securities Act of 1933, as amended (the “Securities Act”), then at the Purchaser’s request, Pubco will
cause Pubco’s transfer agent to remove the legend set forth in Section 1(b)(ii). In connection therewith, if required
by Pubco’s transfer agent, Pubco will promptly cause an opinion of counsel to be delivered to and maintained with its transfer
agent, together with any other authorizations, certificates and directions required by the transfer agent that authorize and direct
the transfer agent to transfer such Pubco Forward Purchase Securities without any such legend; provided, however,
that Pubco will not be required to deliver any such opinion, authorization or certificate or direction if it reasonably believes
that removal of the legend could result in or facilitate transfers of Pubco Forward Purchase Securities in violation of applicable
law.

 

    4

     

    

 

		2.	Representations and Warranties of the Purchaser. The Purchaser represents and warrants to
Pubco and the Company as follows, as of the date hereof:

 

		(a)	Organization and Power. The Purchaser is duly organized, validly existing, and in good standing
under the laws of the jurisdiction of its formation and has all requisite power and authority to carry on its business as presently
conducted and as proposed to be conducted.

 

		(b)	Authorization. The Purchaser has full power and authority to enter into this Agreement.
This Agreement, when executed and delivered by the Purchaser, will constitute the valid and legally binding obligation of the Purchaser,
enforceable in accordance with its terms, except (a) as limited by applicable bankruptcy, insolvency, reorganization, moratorium,
fraudulent conveyance and any other laws of general application affecting enforcement of creditors’ rights generally or (b)
as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies.

 

		(c)	Governmental Consents and Filings. No consent, approval, order or authorization of, or registration,
qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part
of the Purchaser in connection with the consummation of the transactions contemplated by this Agreement.

 

		(d)	Compliance with Other Instruments. The execution, delivery and performance by the Purchaser
of this Agreement and the consummation by the Purchaser of the transactions contemplated by this Agreement will not result in any
violation or default (i) of any provisions of its organizational documents, (ii) of any instrument, judgment, order, writ or decree
to which it is a party or by which it is bound, (iii) under any note, indenture or mortgage to which it is a party or by which
it is bound, (iv) under any lease, agreement, contract or purchase order to which it is a party or by which it is bound or (v)
of any provision of federal or state statute, rule or regulation applicable to the Purchaser, in each case (other than clause (i)),
which would have a material adverse effect on the Purchaser or its ability to consummate the transactions contemplated by this
Agreement.

 

		(e)	Purchase Entirely for Own Account. This Agreement is made with the Purchaser in reliance
upon the Purchaser’s representation to Pubco and the Company, which by the Purchaser’s execution of this Agreement,
the Purchaser hereby confirms, that the Pubco Forward Purchase Securities to be acquired by the Purchaser will be acquired for
investment for the Purchaser’s own account, not as a nominee or agent, and not with a view to the resale or distribution
of any part thereof, and that the Purchaser has no present intention of selling, granting any participation in, or otherwise distributing
the same in violation of law. By executing this Agreement, the Purchaser further represents that the Purchaser does not presently
have any contract, undertaking, agreement or arrangement with any Person to sell, transfer or grant participations to such Person
or to any third Person, with respect to any of the Pubco Forward Purchase Securities. For purposes of this Agreement, “Person”
means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity or any government or any department or agency thereof.

 

    5

     

    

 

		(f)	Disclosure of Information. The Purchaser has had an opportunity to discuss Pubco’s
and the Company’s business, management, financial affairs and the terms and conditions of the offering of the Pubco Forward
Purchase Securities with Pubco’s management.

 

		(g)	Restricted Securities. The Purchaser understands that the offer and sale of the Pubco Forward
Purchase Securities to the Purchaser has not been, and will not be, registered under the Securities Act, by reason of a specific
exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature of
the investment intent and the accuracy of the Purchaser’s representations as expressed herein. The Purchaser understands
that the Pubco Forward Purchase Securities are “restricted securities” under applicable U.S. federal and state securities
laws and that, pursuant to these laws, the Purchaser must hold the Pubco Forward Purchase Securities indefinitely unless they are
registered with the U.S. Securities and Exchange Commission and qualified by state authorities, or an exemption from such registration
and qualification requirements is available. The Purchaser acknowledges that Pubco has no obligation to register or qualify the
Pubco Forward Purchase Securities, or any Pubco Ordinary Shares into which the Pubco Forward Purchase Securities may be converted
into or exercised for, for resale, except pursuant to the New Registration Rights Agreement. The Purchaser further acknowledges
that if an exemption from registration or qualification is available, it may be conditioned on various requirements including,
but not limited to, the time and manner of sale, the holding period for the Pubco Forward Purchase Securities, and on requirements
relating to Pubco which are outside of the Purchaser’s control, and which Pubco is under no obligation and may not be able
to satisfy.

 

		(h)	No Public Market. The Purchaser understands that no public market now exists for the Pubco
Forward Purchase Securities, and that Pubco has made no assurances that a public market will ever exist for the Pubco Forward Purchase
Securities.

 

		(i)	High Degree of Risk. The Purchaser understands that its agreement to purchase the Pubco
Forward Purchase Securities involves a high degree of risk which could cause the Purchaser to lose all or part of its investment.

 

		(j)	Accredited Investor. The Purchaser is an “accredited investor” as defined in
Rule 501(a) of Regulation D promulgated under the Securities Act.

 

		(k)	No General Solicitation. Neither the Purchaser, nor any of its officers, directors, employees,
agents, shareholders or partners has either directly or indirectly, including, through a broker or finder (i) engaged in any general
solicitation, or (ii) published any advertisement in connection with the offer and sale of the Pubco Forward Purchase Securities.

 

    6

     

    

 

		(l)	Non-Public Information. The Purchaser acknowledges its obligations under applicable securities
laws with respect to the treatment of material non-public information relating to Pubco.

 

		(m)	Adequacy of Financing. The Purchaser has available to it sufficient funds to satisfy its
obligations under this Agreement.

 

		(n)	No Other Representations and Warranties; Non-Reliance. Except for the specific representations
and warranties contained in this Section 2 and in any certificate or agreement delivered pursuant hereto, none of the Purchaser
nor any person acting on behalf of the Purchaser nor any of the Purchaser’s affiliates (the “Purchaser Parties”)
has made, makes or shall be deemed to make any other express or implied representation or warranty with respect to the Purchaser
and this offering, and the Purchaser Parties disclaim any such representation or warranty. Except for the specific representations
and warranties expressly made by Pubco and the Company in Section 3 and Section 4 of this Agreement, respectively,
and in any certificate or agreement delivered pursuant hereto, the Purchaser Parties specifically disclaim that they are relying
upon any other representations or warranties that may have been made by Pubco, any person on behalf of Pubco or any of Pubco’s
affiliates (collectively, the “Pubco Parties”).

 

		3.	Representations and Warranties of Pubco. Pubco represents and warrants to the Purchaser and
the Company as follows:

 

		(a)	Incorporation and Corporate Power. Pubco is a business company with limited liability duly
incorporated and validly existing and in good standing under the laws of the British Virgin Islands and has all requisite corporate
power and authority to carry on its business as now being conducted. As of the date hereof, Pubco does not have any Subsidiaries
or own any equity interests in any other Person.

 

		(b)	Capitalization. As of the date hereof, Pubco is authorized to issue a maximum of 50,000
of Pubco Ordinary Shares, of which one (1) Pubco Ordinary Share is issued and outstanding, which is owned by AF.

 

		(c)	Authorization. All corporate action required to be taken by Pubco’s Board of Directors
and shareholders in order to authorize Pubco to enter into this Agreement, and to issue the Pubco Forward Purchase Securities at
the FPS Closing, and the securities issuable upon conversion or exercise of the Pubco Forward Purchase Securities, has been taken
or will be taken prior to the FPS Closing, as applicable. All action on the part of the shareholders, directors and officers of
Pubco necessary for the execution and delivery of this Agreement, the performance of all obligations of Pubco under this Agreement
to be performed as of the FPS Closing, and the issuance and delivery of the Pubco Forward Purchase Securities and the securities
issuable upon conversion or exercise of the Pubco Forward Purchase Securities has been taken or will be taken prior to the FPS
Closing. This Agreement, when executed and delivered by Pubco, shall constitute the valid and legally binding obligation of Pubco,
enforceable against Pubco in accordance with its terms except (i) as limited by applicable bankruptcy, insolvency, reorganization,
moratorium, fraudulent conveyance, or other laws of general application relating to or affecting the enforcement of creditors’
rights generally or (ii) as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable
remedies.

 

    7

     

    

 

		(d)	Valid Issuance of Securities.

 

		(i)	The Pubco Forward Purchase Securities, when issued, sold and delivered in accordance with the terms
of, and for the consideration set forth in, this Agreement and Pubco’s memorandum and articles of association, as they may
be amended from time to time (the “Pubco Charter”), and registered in the register of members of Pubco, and
the securities issuable upon conversion or exercise of the Pubco Forward Purchase Securities, when issued in accordance with the
terms of the Pubco Forward Purchase Securities and this Agreement, and registered in the register of members of Pubco, will be
validly issued, fully paid and nonassessable and free of all preemptive or similar rights, taxes, liens, encumbrances and charges
with respect to the issue thereof and restrictions on transfer other than restrictions on transfer specified under this Agreement,
applicable state and federal securities laws and liens or encumbrances created by or imposed by the Purchaser. Assuming the accuracy
of the representations of the Purchaser in this Agreement and subject to the filings described in Section 3(e) below, the
Pubco Forward Purchase Securities and the securities issuable upon conversion of the Pubco Forward Purchase Securities will be
issued in compliance with all applicable federal and state securities laws.

 

		(ii)	No “bad actor” disqualifying event described in Rule 506(d)(1)(i)-(viii) of the Securities
Act (a “Disqualification Event”) is applicable to Pubco or, to Pubco’s knowledge, any Pubco Covered Person
(as defined below), except for a Disqualification Event as to which Rule 506(d)(2)(ii—iv) or (d)(3), is applicable. “Pubco
Covered Person” means, with respect to Pubco as an “issuer” for purposes of Rule 506 promulgated under the
Securities Act, any Person listed in the first paragraph of Rule 506(d)(1).

 

		(e)	Governmental Consents and Filings. Assuming the accuracy of the representations and warranties
made by the Purchaser in this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation,
declaration or filing with, any federal, state or local governmental authority is required on the part of Pubco in connection with
the consummation of the transactions contemplated by this Agreement, except for filings pursuant to Regulation D of the Securities
Act, and applicable state securities laws.

 

    8

     

    

 

		(f)	Compliance with Other Instruments. The execution, delivery and performance of this Agreement
and the consummation of the transactions contemplated by this Agreement will not result in any violation or default (i) of any
provisions of the Pubco Charter or its other governing documents, (ii) of any instrument, judgment, order, writ or decree to which
it is a party or by which it is bound, (iii) under any note, indenture or mortgage to which it is a party or by which it is bound,
(iv) under any lease, agreement, contract or purchase order to which it is a party or by which it is bound or (v) of any provision
of federal or state statute, rule or regulation applicable to Pubco, in each case (other than clause (i)) which would have a material
adverse effect on Pubco or its ability to consummate the transactions contemplated by this Agreement.

 

		(g)	Operations. As of the date hereof, Pubco has not conducted any operations other than organizational
activities, activities conducted in connection with exploring a possible Business Combination, activities in connection with the
Transaction contemplated by the Business Combination Agreement and the offerings of the Pubco Forward Purchase Securities.

 

		(h)	Foreign Corrupt Practices. Neither Pubco, nor any director, officer, agent, employee or
other Person acting on behalf of Pubco has, in the course of its actions for, or on behalf of, Pubco (i) used any corporate funds
for any unlawful contribution, gift, entertainment or other unlawful expenses relating to political activity, (ii) made any direct
or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds, (iii) violated or
is in violation of any provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended, or (iv) made any unlawful bribe,
rebate, payoff, influence payment, kickback or other unlawful payment to any foreign or domestic government official or employee.

 

		(i)	Compliance with Anti-Money Laundering Laws. The operations of Pubco are and have been conducted
at all times in compliance with applicable financial recordkeeping and reporting requirements and all other applicable U.S. and
non-U.S. anti-money laundering laws and regulations, including, but not limited to, those of the Currency and Foreign Transactions
Reporting Act of 1970, as amended, the USA Patriot Act of 2001 and the applicable money laundering statutes of all applicable jurisdictions,
the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced
by any governmental agency (collectively, the “Anti-Money Laundering Laws”), and no action, suit or proceeding
by or before any court or governmental agency, authority or body or any arbitrator involving Pubco with respect to the Anti-Money
Laundering Laws is pending or, to the knowledge of Pubco, threatened.

 

		(j)	Absence of Litigation. There is no action, suit, proceeding, inquiry or investigation before
or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of Pubco, threatened
against or affecting Pubco or any of Pubco’s officers or directors, whether of a civil or criminal nature or otherwise, in
their capacities as such.

 

		(k)	No General Solicitation. Neither Pubco, nor any of its officers, directors, employees, agents
or shareholders has either directly or indirectly, including, through a broker or finder (i) engaged in any general solicitation,
or (ii) published any advertisement in connection with the offer and sale of the Pubco Forward Purchase Securities.

 

    9

     

    

 

		(l)	No Other Representations and Warranties; Non-Reliance. Except for the specific representations
and warranties contained in this Section 3 and in any certificate or agreement delivered pursuant hereto, none of the Purchaser
Parties has made, makes or shall be deemed to make any other express or implied representation or warranty with respect to the
Purchaser or this offering, and the Pubco Parties disclaim any such representation or warranty. Except for the specific representations
and warranties expressly made by the Purchaser and the Company in Section 2 and Section 4 of this Agreement, respectively,
and in any certificate or agreement delivered pursuant hereto, the Pubco Parties specifically disclaim that they are relying upon
any other representations or warranties that may have been made by the Purchaser Parties.

 

		4.	Representations and Warranties of the Company. The Company represents and warrants to the
Purchaser and Pubco as follows:

 

		(a)	Incorporation and Corporate Power. The Company is a business company with limited liability
company duly incorporated and validly existing and in good standing under the laws of the British Virgin Islands and has all requisite
corporate power and authority to carry on its business as presently conducted and as proposed to be conducted. The Company has
no subsidiaries.

 

		(b)	Authorization. All corporate action required to be taken by the Company’s Board of
Directors and shareholders in order to authorize the Company to enter into this Agreement has been taken or will be taken prior
to the FPS Closing, as applicable. All action on the part of the shareholders, directors and officers of the Company necessary
for the execution and delivery of this Agreement, the performance of all obligations of the Company under this Agreement to be
performed as of the FPS Closing has been taken or will be taken prior to the FPS Closing. This Agreement, when executed and delivered
by the Company, shall constitute the valid and legally binding obligation of the Company, enforceable against the Company in accordance
with its terms except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or
other laws of general application relating to or affecting the enforcement of creditors’ rights generally or (ii) as limited
by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies.

 

		(c)	Compliance with Other Instruments. The execution, delivery and performance of this Agreement
and the consummation of the transactions contemplated by this Agreement will not result in any violation or default (i) of any
provisions of the he Company’s memorandum and articles of association, as they may be amended from time to time, or its other
governing documents, (ii) of any instrument, judgment, order, writ or decree to which it is a party or by which it is bound, (iii)
under any note, indenture or mortgage to which it is a party or by which it is bound, (iv) under any lease, agreement, contract
or purchase order to which it is a party or by which it is bound or (v) of any provision of federal or state statute, rule or regulation
applicable to the Company, in each case (other than clause (i)) which would have a material adverse effect on the Company or its
ability to consummate the transactions contemplated by this Agreement.

 

    10

     

    

 

		(d)	Foreign Corrupt Practices. Neither the Company, nor any director, officer, agent, employee
or other Person acting on behalf of the Company has, in the course of its actions for, or on behalf of, the Company (i) used any
corporate funds for any unlawful contribution, gift, entertainment or other unlawful expenses relating to political activity, (ii)
made any direct or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds, (iii)
violated or is in violation of any provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended or (iv) made any unlawful
bribe, rebate, payoff, influence payment, kickback or other unlawful payment to any foreign or domestic government official or
employee.

 

		(e)	Compliance with Anti-Money Laundering Laws. The operations of the Company are and have been
conducted at all times in compliance with Anti-Money Laundering Laws, and no action, suit or proceeding by or before any court
or governmental agency, authority or body or any arbitrator involving the Company with respect to the Anti-Money Laundering Laws
is pending or, to the knowledge of the Company, threatened.

 

		(f)	Absence of Litigation. There is no action, suit, proceeding, inquiry or investigation before
or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company,
threatened against or affecting the Company or any of the Company’s officers or directors, whether of a civil or criminal
nature or otherwise, in their capacities as such.

 

		(g)	No Other Representations and Warranties; Non-Reliance. Except for the specific representations
and warranties contained in this Section 4 and in any certificate or agreement delivered pursuant hereto, none of the Company
nor any person acting on behalf of the Company nor any of the Company’s affiliates (the “Company Parties”)
has made, makes or shall be deemed to make any other express or implied representation or warranty with respect to the Company
and the Business Combination, and the Company Parties disclaim any such representation or warranty. Except for the specific representations
and warranties expressly made by the Purchaser and Pubco in Section 2 and Section 3 of this Agreement, respectively,
and in any certificate or agreement delivered pursuant hereto, the Company Parties specifically disclaim that they are relying
upon any other representations or warranties that may have been made by the Purchaser Parties or the Pubco Parties.

 

    11

     

    

 

		5.	Additional Agreements, Acknowledgements and Waivers.

 

		(a)	Trust Account.

 

		(i)	The Purchaser hereby acknowledges that it is aware that the Company maintains a trust account (the
“Trust Account”) for the benefit of its public shareholders. The Purchaser, for itself and its affiliates, hereby
agrees that it has no right, title, interest or claim of any kind in or to any monies held in the Trust Account, or any other asset
of the Company as a result of any liquidation of the Company, except for redemption and liquidation rights, if any, the Purchaser
may have in respect of any Company Ordinary Shares held by the Purchaser.

 

		(ii)	The Purchaser hereby agrees that it shall have no right of set-off or any right, title, interest
or claim of any kind (“Claim”) to, or to any monies in, the Trust Account, and hereby irrevocably waives any
Claim to, or to any monies in, the Trust Account that it may have now or in the future, except for redemption and liquidation rights,
if any, the Purchaser may have in respect of any Company Ordinary Shares held by it. In the event the Purchaser has any Claim against
the Company under this Agreement, the Purchaser shall pursue such Claim solely against the Company and its assets outside the Trust
Account and not against the property or any monies in the Trust Account, except for redemption and liquidation rights, if any,
the Purchaser may have in respect of any Company Ordinary Shares held by the Purchaser.

 

		(b)	No Short Sales. The Purchaser hereby agrees that neither it, nor any person or entity acting
on its behalf or pursuant to any understanding with it, will engage in any Short Sales with respect to securities of Pubco prior
to the Share Acquisition Closing. For purposes of this Section 5, “Short Sales” shall include, without
limitation, all “short sales” as defined in Rule 200 promulgated under Regulation SHO under the Securities Exchange
Act of 1934, as amended (the “Exchange Act”) and all types of direct and indirect stock pledges (other than
pledges in the ordinary course of business as part of prime brokerage arrangements), forward sale contracts, options, puts, calls,
swaps and similar arrangements (including on a total return basis), and sales and other transactions through non-U.S. broker dealers
or foreign regulated brokers.

 

		(c)	Nasdaq Listing. Pubco will use commercially reasonable best efforts to effect and maintain
the listing of the Pubco Ordinary Shares and Pubco Public Warrants on the Nasdaq Market (or another national securities exchange).

 

		(d)	Share Acquisition Closing. The Purchaser and Pubco hereby acknowledge that the Share Acquisition
Closing shall be completed promptly following the purchase of Pubco Forward Purchase Securities, in accordance with the terms and
conditions set forth in the Business Combination Agreement.

 

    12

     

    

 

		6.	FPS Closing Conditions.

 

		(a)	The obligation of the Purchaser to purchase the Pubco Forward Purchase Securities at the FPS Closing
under this Agreement shall be subject to the fulfillment, at or prior to the FPS Closing, of each of the following conditions,
any of which, to the extent permitted by applicable laws, may be waived by the Purchaser:

 

		(i)	Pubco shall have delivered to the Purchaser a certificate evidencing the Pubco’s good standing
as a British Virgin Islands business company with limited liability, as of a date within ten (10) Business Days of the FPS Closing;

 

		(ii)	The representations and warranties of Pubco set forth in Section 3 of this Agreement shall
have been true and correct as of the date hereof and shall be true and correct as of the FPS Closing, as applicable, with the same
effect as though such representations and warranties had been made on and as of such date (other than any such representation or
warranty that is made by its terms as of a specified date, which shall be true and correct as of such specified date), except where
the failure to be so true and correct would not have a material adverse effect on Pubco or its ability to consummate the transactions
contemplated by this Agreement;

 

		(iii)	Pubco shall have performed, satisfied and complied in all material respects with the covenants,
agreements and conditions required by this Agreement to be performed, satisfied or complied with by Pubco at or prior to the FPS
Closing; and

 

		(iv)	No order, writ, judgment, injunction, decree, determination, or award shall have been entered by
or with any governmental, regulatory, or administrative authority or any court, tribunal, or judicial, or arbitral body, and no
other legal restraint or prohibition shall be in effect, preventing the purchase by the Purchaser of the Pubco Forward Purchase
Securities.

 

		(b)	The obligation of Pubco to sell the Pubco Forward Purchase Securities at the FPS Closing under
this Agreement shall be subject to the fulfillment, at or prior to the FPS Closing, of each of the following conditions, any of
which, to the extent permitted by applicable laws, may be waived by Pubco:

 

		(i)	The representations and warranties of the Purchaser set forth in Section 2 of this Agreement
shall have been true and correct as of the date hereof and shall be true and correct as of the FPS Closing, as applicable, with
the same effect as though such representations and warranties had been made on and as of such date (other than any such representation
or warranty that is made by its terms as of a specified date, which shall be true and correct as of such specified date), except
where the failure to be so true and correct would not have a material adverse effect on the Purchaser or its ability to consummate
the transactions contemplated by this Agreement;

 

    13

     

    

 

		(ii)	The Purchaser shall have performed, satisfied and complied in all material respects with the covenants,
agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Purchaser at or prior to
the FPS Closing; and

 

		(iii)	No order, writ, judgment, injunction, decree, determination, or award shall have been entered by
or with any governmental, regulatory, or administrative authority or any court, tribunal, or judicial, or arbitral body, and no
other legal restraint or prohibition shall be in effect, preventing the purchase by the Purchaser of the Pubco Forward Purchase
Securities.

 

		7.	Termination. This Agreement may be terminated at any time prior to the FPS Closing:

 

		(a)	by mutual written consent of the Purchaser, Pubco and, prior to the Merger Closing, the Company;
or

 

		(b)	automatically if the Business Combination Agreement is terminated.

 

In the event
of any termination of this Agreement pursuant to this Section 7, the FPS Purchase Price (and interest thereon, if any),
if previously paid, and all Purchaser’s funds paid in connection herewith shall be promptly returned to the Purchaser, and
thereafter this Agreement shall forthwith become null and void and have no effect, without any liability on the part of the Purchaser
or the Company and their respective directors, officers, employees, partners, managers, members, or shareholders and all rights
and obligations of each party shall cease; provided, however, that nothing contained in this Section 6 shall
relieve either party from liabilities or damages arising out of any fraud or willful breach by such party of any of its representations,
warranties, covenants or agreements contained in this Agreement.

 

		8.	General Provisions.

 

		(a)	Notices. All notices, consents, waivers and other communications given or made pursuant
to this Agreement shall be in writing and shall be deemed effectively given upon the earlier of actual receipt, or (i) personal
delivery to the party to be notified, (ii) when sent, if sent by electronic mail or facsimile (if any) during normal business hours
of the recipient, and if not sent during normal business hours, then on the recipient’s next Business Day, (iii) five (5)
Business Days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (iv) one (1)
Business Day after deposit with a nationally recognized overnight courier, freight prepaid, specifying next Business Day delivery,
with written verification of receipt; provided, however, that notice given pursuant to clauses (iii) and (iv) above
shall not be effective unless a duplicate copy of such notice is also given in person or by e-mail.

 

    14

     

    

 

All communications
sent to Pubco shall be sent to:

 

Nexters Inc.

55, Griva Digeni, 3101

Limassol, Cyprus

Attn: Andrey Fadeev

Email: fadanrd@gmail.com

 

All communications
sent to the Company prior to the Share Acquisition Closing shall be sent to:

 

Kismet Acquisition One Corp.

Ritter House, Wickhams Cay II,

PO Box 3170, Road Town, Tortola

VG1110 British Virgin Islands

Attn: Ivan Tavrin, Chief Executive Officer

Email: tioffice@kismetcg.com

 

with a copy to the Company’s counsel at:

Skadden, Arps, Slate, Meagher & Flom (UK) LLP

40 Bank Street

Canary Wharf

London E14 5DS

United Kingdom

Attn: Denis Klimentchenko

Email: Denis.Klimentchenko@skadden.com

 

All communications sent to the Purchaser shall be sent
to:

 

Kismet Sponsor Limited

Ritter House, Wickhams Cay II,

PO Box 3170, Road Town, Tortola

VG1110 British Virgin Islands

Attn: Natalia Markekova

Email: nmarkelova@kismet-group.com

 

All communications
to the Purchaser shall be sent to the Purchaser’s address as set forth on the signature page hereof, or to such e-mail address,
facsimile number (if any) or address as subsequently modified by written notice given in accordance with this Section 8(a).

 

		(b)	No Finder’s Fees. Other than fees payable to Credit Suisse Securities (USA) LLC, BofA
Securities, Inc. and LionTree LLC, which shall be the responsibility of the Company, each party represents that it neither is nor
will be obligated for any finder’s fee or commission in connection with this transaction. The Purchaser agrees to indemnify
and to hold harmless Pubco and the Company from any liability for any commission or compensation in the nature of a finder’s
or broker’s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted
liability) for which the Purchaser, the Company or any of their respective officers, employees or representatives is responsible.

 

    15

     

    

 

		(c)	Survival of Representations and Warranties. All of the representations and warranties contained
herein shall survive the FPS Closing.

 

		(d)	Entire Agreement. This Agreement, together with any documents, instruments and writings
that are delivered pursuant hereto or referenced herein, constitutes the entire agreement and understanding of the parties hereto
in respect of its subject matter and supersedes all prior understandings, agreements, or representations by or among the parties
hereto, written or oral, to the extent they relate in any way to the subject matter hereof or the transactions contemplated hereby.

 

		(e)	Successors. All of the terms, agreements, covenants, representations, warranties, and conditions
of this Agreement are binding upon, and inure to the benefit of and are enforceable by, the parties hereto and their respective
successors. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or
their respective successors and assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement,
except as expressly provided in this Agreement.

 

		(f)	Assignments. Except as otherwise specifically provided herein, no party hereto may assign
either this Agreement or any of its rights, interests, or obligations hereunder without the prior written approval of the other
parties except that the Purchaser may assign its rights, interests, or obligations hereunder to any of its affiliates, provided,
however, that no such assignment or delegation shall relieve the Purchaser of its obligations hereunder and Pubco shall be entitled
to pursue all rights and remedies against the Purchaser subject to the terms and conditions hereof.

 

		(g)	Counterparts. This Agreement may be executed in two or more counterparts, each of which
will be deemed an original but all of which together will constitute one and the same instrument.

 

		(h)	Headings. The section headings contained in this Agreement are inserted for convenience
only and will not affect in any way the meaning or interpretation of this Agreement.

 

		(i)	Governing Law. This Agreement, the entire relationship of the parties hereto, and any dispute
between the parties (whether grounded in contract, tort, statute, law or equity) shall be governed by, construed in accordance
with, and interpreted pursuant to, the laws of the State of New York, without giving effect to its choice of laws principles.

 

		(j)	Jurisdiction. The parties (i) hereby irrevocably and unconditionally submit to the jurisdiction
of the state courts of New York and to the jurisdiction of the United States District Court for the Southern District of New York
for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (ii) agree not to commence
any suit, action or other proceeding arising out of or based upon this Agreement except in state courts of New York or the United
States District Court for the Southern District of New York, and (iii) hereby waive, and agree not to assert, by way of motion,
as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction
of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding
is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the
subject matter hereof may not be enforced in or by such court.

 

    16

     

    

 

		(k)	Waiver of Jury Trial. The parties hereto hereby waive any right to a jury trial in connection
with any litigation pursuant to this Agreement and the transactions contemplated hereby.

 

		(l)	Amendments. This Agreement may not be amended, modified or waived as to any particular provision,
except with the prior written consent of Pubco, the Purchaser and, prior to the Merger Closing, the Company.

 

		(m)	Severability. The provisions of this Agreement will be deemed severable and the invalidity
or unenforceability of any provision will not affect the validity or enforceability of the other provisions hereof; provided
that if any provision of this Agreement, as applied to any party hereto or to any circumstance, is adjudged by a governmental authority,
arbitrator, or mediator not to be enforceable in accordance with its terms, the parties hereto agree that the governmental authority,
arbitrator, or mediator making such determination will have the power to modify the provision in a manner consistent with its objectives
such that it is enforceable, and/or to delete specific words or phrases, and in its reduced form, such provision will then be enforceable
and will be enforced.

 

		(n)	Expenses. Each party will bear its own costs and expenses incurred in connection with the
preparation, execution and performance of this Agreement and the consummation of the transactions contemplated hereby, including
all fees and expenses of agents, representatives, financial advisors, legal counsel and accountants. Pubco shall be responsible
for the fees of its transfer agent; stamp taxes and all of The Depository Trust Company’s fees associated with the issuance
of the Pubco Forward Purchase Securities and the securities issuable upon conversion or exercise of the Pubco Forward Purchase
Securities.

 

		(o)	Construction. The parties hereto have participated jointly in the negotiation and drafting
of this Agreement. If an ambiguity or question of intent or interpretation arises, this Agreement will be construed as if drafted
jointly by the parties hereto and no presumption or burden of proof will arise favoring or disfavoring any party hereto because
of the authorship of any provision of this Agreement. Any reference to any federal, state, local, or foreign law will be deemed
also to refer to law as amended and all rules and regulations promulgated thereunder, unless the context requires otherwise. The
words “include,” “includes,” and “including” will be deemed to be followed
by “without limitation.” Pronouns in masculine, feminine, and neuter genders will be construed to include any
other gender, and words in the singular form will be construed to include the plural and vice versa, unless the context otherwise
requires. The words “this Agreement,” “herein,” “hereof,” “hereby,”
“hereunder,” and words of similar import refer to this Agreement as a whole and not to any particular subdivision
unless expressly so limited. The parties hereto intend that each representation, warranty, and covenant contained herein will have
independent significance. If any party hereto has breached any representation, warranty, or covenant contained herein in any respect,
the fact that there exists another representation, warranty or covenant relating to the same subject matter (regardless of the
relative levels of specificity) which such party hereto has not breached will not detract from or mitigate the fact that such party
hereto is in breach of the first representation, warranty, or covenant.

  

		(p)	Waiver. No waiver by any party hereto of any default, misrepresentation, or breach of warranty
or covenant hereunder, whether intentional or not, may be deemed to extend to any prior or subsequent default, misrepresentation,
or breach of warranty or covenant hereunder or affect in any way any rights arising because of any prior or subsequent occurrence.

 

		(q)	Confidentiality. Except as may be required by law, regulation or applicable stock exchange
listing requirements, unless and until the transactions contemplated hereby and the terms hereof are publicly announced or otherwise
publicly disclosed by Pubco, the parties hereto shall keep confidential and shall not publicly disclose the existence or terms
of this Agreement.

 

		(r)	Specific Performance. The Purchaser agrees that irreparable damage may occur in the event
any provision of this Agreement was not performed by the Purchaser in accordance with the terms hereof and that Pubco and, prior
to the Merger Closing, the Company, shall be entitled to specific performance of the terms hereof, in addition to any other remedy
at law or equity.

 

[Signature Page Follows]

 

    17

     

    

 

IN WITNESS WHEREOF, the undersigned
have executed this Agreement to be effective as of the date first set forth above.

 

	 	PURCHASER:
	 	KISMET SPONSOR LIMITED
	 	 
	 	By:	/s/ Natalia Markelova
	 	 	Name:  	Natalia Markelova
	 	 	Title:	Director
	 	 
	 	PUBCO:
	 	NEXTERS INC.
	 	 	 	 
	 	By:	/s/ Andrey Fadeev
	 	 	Name:	Andrey Fadeev
	 	 	Title:	Sole Director
	 	 	 	 
	 	COMPANY:
	 	KISMET ACQUISITION ONE CORP
	 	 
	 	By:	/s/ Ivan Tavrin
	 	 	Name:	Ivan Tavrin
	 	 	Title:	Chief Executive Officer

 

 

18

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00320-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00320-of-00352.parquet"}]]